NasdaqCM - Delayed Quote USD

Dyadic International, Inc. (DYAI)

0.9400
-0.0042
(-0.44%)
At close: June 13 at 4:00:00 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Mark A. Emalfarb Founder, CEO & Director 841.67k -- 1956
Mr. Joseph P. Hazelton President & COO 380.81k -- 1976
Ms. Ping Wang Rawson CPA, M.B.A. Chief Financial Officer 344.83k -- 1975
Ms. Ana Gómez Rodriguez Secretary of the Board -- -- --

Dyadic International, Inc.

1044 North U.S. Highway One
Suite 201
Jupiter, FL 33477-5094
United States
561 743 8333 https://www.dyadic.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
6

Description

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Corporate Governance

Dyadic International, Inc.’s ISS Governance QualityScore as of June 1, 2025 is 7. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 9; Compensation: 6.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 11, 2025 at 10:59 AM UTC - August 15, 2025 at 12:00 PM UTC

Dyadic International, Inc. Earnings Date

Recent Events

June 2, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 14, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 5, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

April 29, 2025 at 12:00 AM UTC

DEFA14A: Proxy Statements

March 31, 2025 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

March 26, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 20, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 8, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

Related Tickers